BET bromodomain targeting suppresses the PD-1/PD-L1 pathway in triple-negative breast cancer and elicits anti-tumor immune response

被引：0
|
作者：
Andrieu, Guillaume [1 ]
Shafran, Jordan S. [2 ]
Denis, Gerald V. [2 ]
机构：
[1] Inst Necker Enfants Malades, Paris, France
[2] Boston Univ, Sch Med, Boston, MA 02215 USA
来源：
JOURNAL OF IMMUNOLOGY | 2019年 / 202卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
182.87
引用
收藏
页数：1
相关论文
共 50 条
  • [1] BET protein targeting suppresses the PD-1/PD-L1 pathway in triple-negative breast cancer and elicits anti-tumor immune response
    Andrieu, Guillaume P.
    Shafran, Jordan S.
    Smith, Charlotte L.
    Belkina, Anna C.
    Casey, Allison N.
    Jafari, Naser
    Denis, Gerald V.
    CANCER LETTERS, 2019, 465 : 45 - 58
  • [2] Immunotherapy Targeting PD-1/PD-L1 in Early-Stage Triple-Negative Breast Cancer
    Yang, Tinglin
    Li, Wenhui
    Huang, Tao
    Zhou, Jun
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (03):
  • [3] Progress of PD-1/PD-L1 immune checkpoint inhibitors in the treatment of triple-negative breast cancer
    Hongshu Li
    Ying Chang
    Tiefeng Jin
    Meihua Zhang
    Cancer Cell International, 25 (1)
  • [4] Effects of Cardamonin on PD-1/PD-L1 Checkpoint in Triple-Negative Breast Cancer
    Mendonca, Patricia
    Hill, Lonnie
    Soliman, Karam F. A.
    FASEB JOURNAL, 2022, 36
  • [5] PD-1 Independent Role of PD-L1 in Triple-Negative Breast Cancer Progression
    Alkaabi, Duaa
    Arafat, Kholoud
    Sulaiman, Shahrazad
    Al-Azawi, Aya Mudhafar
    Attoub, Samir
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [6] Effect of PD-1 and PD-L1 in the tumor microenvironment on overall survival of triple-negative breast cancer patients
    Linnaus, M. E.
    Kosiorek, H.
    Barrett, M. T.
    Dueck, A.
    Anderson, K. S.
    Ocal, I. T.
    McCullough, A. E.
    Annamalai, L.
    Yearley, J. H.
    Pockaj, B. A.
    CANCER RESEARCH, 2017, 77
  • [7] Adipocyte PD-L1 suppresses anti-tumor immune response and promotes breast cancer progression
    Wu, Bogang
    Sun, Xiujie
    Gupta, Harshita B.
    Yuan, Bin
    Chiang, Huai-Chin
    Hu, Yanfen
    Curiel, Tyler J.
    Li, Rong
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [8] Future of PD-1/PD-L1 axis modulation for the treatment of triple-negative breast cancer
    Nakhjavani, Maryam
    Shigdar, Sarah
    PHARMACOLOGICAL RESEARCH, 2022, 175
  • [9] A multitier virtual screening of antagonists targeting PD-1/PD-L1 interface for the management of triple-negative breast cancer
    Krishnamoorthy, HemaNandini Rajendran
    Karuppasamy, Ramanathan
    MEDICAL ONCOLOGY, 2023, 40 (11)
  • [10] A multitier virtual screening of antagonists targeting PD-1/PD-L1 interface for the management of triple-negative breast cancer
    HemaNandini Rajendran Krishnamoorthy
    Ramanathan Karuppasamy
    Medical Oncology, 40
12345